The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1

Blood

Volumn 97, Issue 10, 2001, Pages 2941-2947

  Li, Bao Qun ^a,b   Wetzel, Michele A ^a,b   Mikovits, Judy A ^a,b   Henderson, Earl E ^a,b   Rogers, Thomas J ^a,b   Gong, Wanghua ^a,b   Le, Yingying ^a,b   Ruscetti, Francis W ^a,b   Wang, Ji Ming ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE; FORMYLPEPTIDE RECEPTOR LIKE 1 PROTEIN; FORMYLPEPTIDE RECEPTOR LIKE 1 PROTEIN AGONIST; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN GP 120; STAUROSPORINE; TRYPTOPHANYLLYSYLTYROSYLMETHIONYLVALINE; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL LINE; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; T LYMPHOCYTE; VIRUS STRAIN;

EID: 0035874534     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.10.2941     Document Type: Article

References (26)

1. Rollins BJ. Chemokines. Blood. 1997;90:909-926.
2. Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994;12:593-633.
3. Ali H, Richardson RM, Haribabu B, Snyderman R. Chemoattractant receptor cross-desensitization. J Biol Chem. 1999;274:6027-6030.
4. Oppermann M, Mack M, Proudfoot AE, Olbrich H. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J Biol Chem. 1999;274:8875-8885.
5. Rodriguez-Frade JM, Vila-Coro AJ, Martin A, et al. Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis. J Cell Biol. 1999;44:755-765.
6. Murphy PM. The N-formyl peptide chemotactic receptors. In: Horuk R, ed. Chemoattractant Ligands and Their Receptors. Boca Raton, FL: CRC Press; 1996:269-299.
7. Prossnitz ER, Ye RD. The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol Ther. 1997;74:73-102.
8. Fiore S, Maddox JF, Perez HD, Serhan CN. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med. 1994;180;253-260.
9. Su SB, Gong W, Gao J-L, et al. A seven-transmembrane, G-protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med. 1999;189:395-402.
10. Su SB, Gong W, Gao J-L, et al. T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood. 1999;93:3885-3892.
11. Su SB, Gao J-L, Gong W, et al. T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G protein-coupled formyl peptide receptors. J Immunol. 1999;162:5924-5930.
12. Deng X, Ueda H, Su SB, et al. A synthetic peptide derived from HIV-1 gp120 down-regulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the seven-transmembrane G protein-coupled receptor FPRL1/LXA4R. Blood. 1999;94:1165-1173.
13. Shen W, Proost P, Li B, et al. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. Biochem Biophys Res Commun. 2000;272:276-283.
14. Le Y, Gong W, Li B, et al. Utilization of two seven transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol. 1999;163:6777-6784.
15. Seo JK, Chio SY, Kim Y, et al. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human nertrophils. J Immunol. 1997;158:1895-1901.
16. + T cells. J Immunol. 1999;162:7128-7132.
17. Nussbaum O, Broder CC, Berger EA. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J Virol. 1994;68:5411-5422.
18. Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for antiinflammatory receptors. J Exp Med. 1997;185:1693-1704.
19. 2+ mobilization. J Immunol. 1996;157:2149-2154.
20. Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem. 1997;272:6972-6978.
21. Shen W, Li B, Wetzel MA, et al. Attenuation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor. Blood. 2000;96:295-306.
22. Badolato R, Johnston JA, Wang JM, et al. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol. 1995;155:4004-4010.
23. Van Drenth C, Jenkins A, Ledwich L, et al. Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56(Ick) enzymatic activity. J Immunol. 2000;165:6356-6363.
24. Mashikian MV, Ryan TC, Seman A, Brazer W, Center DM, Cruikshank WW. Reciprocal desensitization of CCR5 and CD4 is mediated by IL-16 and macrophage-inflammatory protein-1 beta, respectively. J Immunol. 1999;163:3123-3130.
25. Alfano M, Schmidtmayerova H, Amella CA, Pushkarsky T, Bukrinsky M. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains. J Exp Med. 1999;190:597-605.
26. Wang JM, Oppenheim JJ. Interference with the signaling capacity of CC chemokine receptor 5 can compromise its role as an HIV-1 entry coreceptor in primary T lymphocytes. J Exp Med. 1999;190:591-595.